Introduction
The myelodysplastic syndromes (MDS) are clonal stem-cell disorders characterized by ineffective haematopoiesis and a high propensity for transformation into acute myeloid leukaemia (AML)
. Furthermore, recurrent chromosomal aberrations are shared by both MDS and AML, and the occurrence of centrosomal aberrations in these disorders further suggests a potential role of CIN in leukaemogenesis [13] [14] [15] [16] [17] . Given 
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Fluorescence-in situ-hybridization (FISH) was performed as described elsewhere [18] , hybridizing centromeric probes for chromosomes 1, 6, 7 and 8 (clones pUC1.77, pEDZ6, p7t1, pZ8.4 , respectively, provided by Mariano Rocchi [19, 20] Fig. 2A and B) [26] . Therefore, since CIN hampers proliferation and induces apoptosis, it might also contribute to progressive cytopenia in MDS [27] [28] [29] [30] .
nCIN does not seem to be generally present in MDS and AML, which may be explained by either other forms of genomic instability contributing to leukaemogenesis in the remaining cases or by CIN only transiently occurring in the majority of cases. The latter possibility of genomic instability being mostly a transient phenomenon in the setting of tumourigenesis and tumour progression has been repeatedly postulated [31] and is supported by the recent finding that permanent genomic instability is disadvantageous to malignant cells [3] .
We conclude that the numerical CIN level might be a valuable measure for identifying patients with high-risk MDS more reliably and possibly for predicting progression to AML, and should be evaluated as a diagnostic tool in larger prospective series.
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